TMG releases report chronicling PACS usageTechnology Marketing Group has released a profile of PACS usage in the U.S. Based on the company's census survey data collected from PACS sites around the world, the PACS Benchmarking Report gathers
Technology Marketing Group has released a profile of PACS usage in the U.S. Based on the company's census survey data collected from PACS sites around the world, the PACS Benchmarking Report gathers information from more than 1700 sites, including hospitals with more than 200 beds and imaging centers that perform at least 10,000 procedures per year. Aimed at healthcare providers, the report analyzes average staff configurations, equipment, PACS usage, and annual equipment budgets. The PACS report is the first in a series Des Plaines, IL-based TMG expects to publish based on its census data.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.